journal article·2018-10

Application of tissue‐engineered pericardial patch in rat models of myocardial infarction

Seyedeh Maryam Kameli, Reza Khorramirouz, Sahar Eftekharzadeh, Kiarad Fendereski, Seyedeh Sima Daryabari, Seyed Mohammad Tavangar, Abdol‐Mohammad Kajbafzadeh

Publisher page

Abstract

Abstract Myocardial infarction (MI) is a major cause of mortality and morbidity in industrialized societies. Myocardial tissue engineering is an alternative and promising approach for substituting injured myocardium through development and seeding of appropriate scaffolds. In this study, we investigated the efficacy of using an acellular pericardium to deliver autologous mesenchymal stem cells (MSCs) to the infarcted site for regeneration of the myocardium. MI was induced in two groups of rats; G1 or MI group, and G2 or patch‐implanted group. In G2 group, rats had undergone transplantation of a pericardial patch which was previously seeded with adipose tissue derived MSCs. To evaluate the efficacy of the pericardial patches, biopsies were taken one month after transplantation. In order to evaluate the extent of regeneration, inflammation and fibrosis, histopathological investigations including hematoxylin and eosin (H&E), Sirius Red and trichrome staining were performed. In addition, immunohistochemical investigations by Desmin as well as CD68, CD45 and CD34 antibodies were performed. Furthermore, Tunnel assay was performed to detect the extent of apoptosis. H&E assessments of biopsies from the patch‐implanted group confirmed presence of pre‐seeded pericardium containing MSCs along with neo‐vessels. Immunohistochemical assessments demonstrated higher number of CD34 positive cells and Desmin‐positive cells in the patch implanted group (p < 0.05); these findings are suggestive of cardiomyocyte regeneration in G2 rats. This study demonstrates the advantages of application of natural acellular scaffolds as cell delivery devices and it emphasizes neovascularization following this approach. However, further investigations are required to analyze long‐term cardiac function in recipients. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 2670–2678, 2018.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Mesenchymal stem cell research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Pediatric Urology and Regenerative Medicine Research Center, Children's Medical Center Tehran University of Medical Sciences Tehran Iran

Department of Pathology Shariati Hospital, Tehran University of Medical Sciences Tehran Islamic Republic of Iran

Funding

Tehran University of Medical Sciences and Health Services

References (28)

Show source-provided references
1. 10.1111/j.1749-6632.1995.tb17454.x10.1111/j.1749-6632.1995.tb17454.x ↗
2. 10.1053/pcad.2002.12346610.1053/pcad.2002.123466 ↗
3. 10.1038/3507058710.1038/35070587 ↗
4. 10.1016/j.addr.2007.08.03110.1016/j.addr.2007.08.031 ↗
5. 10.1161/hh0302.10572210.1161/hh0302.105722 ↗
6. 10.1096/fj.05-4715fje10.1096/fj.05-4715fje ↗
7. 10.1089/ten.tea.2011.020210.1089/ten.tea.2011.0202 ↗
8. 10.1080/0894193060077829710.1080/08941930600778297 ↗
9. 10.1111/j.1439-0264.2010.01005.x10.1111/j.1439-0264.2010.01005.x ↗
10. 10.1016/j.addr.2013.12.00410.1016/j.addr.2013.12.004 ↗
11. 10.3389/fphys.2014.0036510.3389/fphys.2014.00365 ↗
12. Cyclosporine A‐nanoparticles enhance the therapeutic benefit of adipose tissue‐derived stem cell transplantation in a swine myocardial infarction model
13. 10.1161/01.CIR.102.suppl_3.III-5610.1161/01.CIR.102.suppl_3.III-56 ↗
14. 10.1111/j.1582-4934.2011.01409.x10.1111/j.1582-4934.2011.01409.x ↗
15. Allogeneic mesenchymal stromal cells transplanted onto the heart surface achieve therapeutic myocardial repair despite immunologic responses in rats10.1161/JAHA.115.002815 ↗
16. 10.1007/s12015-015-9602-z10.1007/s12015-015-9602-z ↗
17. 10.1016/j.yjmcc.2005.05.01210.1016/j.yjmcc.2005.05.012 ↗
18. 10.1038/nm139110.1038/nm1391 ↗
19. 10.1038/srep3708910.1038/srep37089 ↗
20. Decellularization of tissues and organs
21. 10.1016/j.transproceed.2016.07.02610.1016/j.transproceed.2016.07.026 ↗
22. 10.3727/096368909X1248316219676410.3727/096368909X12483162196764 ↗
23. 10.1016/j.biomaterials.2006.06.02210.1016/j.biomaterials.2006.06.022 ↗
24. 10.1016/j.biomaterials.2004.06.01410.1016/j.biomaterials.2004.06.014 ↗
25. 10.1016/j.biomaterials.2009.02.01310.1016/j.biomaterials.2009.02.013 ↗
26. 10.1186/1423-0127-19-9310.1186/1423-0127-19-93 ↗
27. 10.1016/j.biomaterials.2013.09.08310.1016/j.biomaterials.2013.09.083 ↗
28. 10.3727/096368912X65883610.3727/096368912X658836 ↗